glp 1 drugs and cancer GLP-1 linked to lower rates of some cancers Weight-loss drugs now linked to
Description
Discovery of gastric inhibitory polypeptide (GIP) Among those active in the field was John Brown (figure 16), a British-born physiologist, who developed a passion for the gastrointestinal gut while doing a doctorate at the University of Newcastle-upon-Type
BMJ 353, i1585
He had done this while a postdoctoral fellow at Whitehead Institute for Biomedical Research in Cambridge, Massachusetts (Leemans)
doi: 10.1038/304368a0 14 HansenLDeaconCFOrskovCHolstJJ
GLP-1 agonist to treat obesity and prevent cardiovascular disease: What have we achieved so far
